Jason Coloma, Maze CEO

Af­ter FTC scruti­ny of Sanofi deal, Maze finds a new Pompe part­ner in Sh­iono­gi

Maze Ther­a­peu­tics has found a new buy­er for its Pompe dis­ease can­di­date, five months af­ter scruti­ny from the Fed­er­al Trade Com­mis­sion led Sanofi to back …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.